These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2544901)
1. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Little PJ; Compton DR; Mechoulam R; Martin BR Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity. Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Martin BR; Compton DR; Prescott WR; Barrett RL; Razdan RK Drug Alcohol Depend; 1995 Mar; 37(3):231-40. PubMed ID: 7796717 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol. Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of halogenated delta 8-THC analogs. Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915 [TBL] [Abstract][Full Text] [Related]
6. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Howlett AC; Champion TM; Wilken GH; Mechoulam R Neuropharmacology; 1990 Feb; 29(2):161-5. PubMed ID: 2158635 [TBL] [Abstract][Full Text] [Related]
7. Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system of mice. Titishov N; Mechoulam R; Zimmerman AM Pharmacology; 1989; 39(6):337-49. PubMed ID: 2561381 [TBL] [Abstract][Full Text] [Related]
8. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol. Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389 [TBL] [Abstract][Full Text] [Related]
9. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS. Ryan W; Singer M; Razdan RK; Compton DR; Martin BR Life Sci; 1995; 56(23-24):2013-20. PubMed ID: 7776826 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. Yan G; Yin D; Khanolkar AD; Compton DR; Martin BR; Makriyannis A J Med Chem; 1994 Aug; 37(16):2619-22. PubMed ID: 8057304 [TBL] [Abstract][Full Text] [Related]
11. Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice. Onaivi ES; Chakrabarti A; Gwebu ET; Chaudhuri G Behav Brain Res; 1995 Dec; 72(1-2):115-25. PubMed ID: 8788864 [TBL] [Abstract][Full Text] [Related]
12. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice. Watanabe K; Yamamoto I; Yoshimura H Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407 [TBL] [Abstract][Full Text] [Related]
13. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911 [TBL] [Abstract][Full Text] [Related]
14. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons. Järbe TU; Hiltunen AJ; Mechoulam R J Pharmacol Exp Ther; 1989 Sep; 250(3):1000-5. PubMed ID: 2550611 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657 [TBL] [Abstract][Full Text] [Related]
16. Marihuana-like activity of new synthetic tetrahydrocannabinols. Martin BR; Dewey WL; Harris LS; Beckner J Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625 [TBL] [Abstract][Full Text] [Related]
17. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia. Smith PB; Martin BR Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767 [TBL] [Abstract][Full Text] [Related]
19. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of water soluble cannabinoids and related analogs. Compton DR; Martin BR Life Sci; 1990; 46(22):1575-85. PubMed ID: 2352451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]